Healthcare -
Biotechnology - NASDAQ - US
$ 4.39
-1.84 %
$ 37.9 M
Market Cap
-0.36
P/E
KPTI - COST OF REVENUE
Cost of Revenue KPTI - Karyopharm Therapeutics Inc.
6.01 M
LAST VALUE
7.35%
2 YEAR CAGR
20.07%
5 YEAR CAGR
-20.57%
10 YEAR CAGR